FDA will have its hands full in 2012 implementing requirements in the Food Safety Modernization Act, which could push back the publication of other pending and much-anticipated regulations.
But the agency still will try to eke out proposed and final rules related to several OTC drugs as part of its ongoing monographs review, and could propose several label changes that will impact the supplement industry, according to the Department of Health and Human Services’ Jan. 20
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?